GENMAB A/S (GMAB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 1.5B 3B 4.5B FY23: 2.4B FY24: 3.1B FY25: 3.7B FY23 FY24 FY25

Gross Profit Annual

0 1.5B 3B 4.5B FY23: 2.4B FY24: 3B FY25: 3.5B FY23 FY24 FY25

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Annual

0 400M 800M 1.2B FY23: 772M FY24: 972M FY25: 1.1B FY23 FY24 FY25

Net Income Annual

0 400M 800M 1.2B FY23: 631M FY24: 1.1B FY25: 963M FY23 FY24 FY25

Cost of Revenue Annual

0 90M 180M 270M FY23: 33M FY24: 143M FY25: 238M FY23 FY24 FY25

Operating Cash Flow Annual

0 500M 1B 1.5B FY23: 1.1B FY24: 1.1B FY25: 1.2B FY23 FY24 FY25

Free Cash Flow Annual

0 400M 800M 1.2B FY23: 1B FY24: 1.1B FY25: 1.1B FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 25M 50M 75M FY21: 66M FY22: 66M FY23: 65.9M FY24: 64.7M FY25: 62.7M FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.